InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,174.00
(
1.14%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.15
(
-0.05%
)
Bitcoin
61,789.94
(
-0.02%
)
Post# of 704019
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

connor26

Send PM Follow Ignore
Followers 1
Posts 442
Boards Moderated 0
Alias Born 01/08/2003

connor26

Re: EYE_ON_WALLST post# 402304

Monday, 06/20/2005 9:40:00 AM

Monday, June 20, 2005 9:40:00 AM

Post# of 704019
been watching it but what do you make of this

La Jolla (LJPC )
Lupus
Blocks the overproduction of immune cells that attack the kidneys
Status: Riquent has Fast Track designation, and the FDA issued an "approvable" letter in October, 2004, pending a further clinical trial. However, La Jolla warned on May 31 that it doesn't have the financial resources to continue that additional trial.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up